Clinical use of low molecular weight heparins and heparinoids
- PMID: 2451292
- DOI: 10.1055/s-2007-1002764
Clinical use of low molecular weight heparins and heparinoids
Similar articles
-
Low molecular weight heparins and bleeding.Semin Thromb Hemost. 1989 Oct;15(4):401-4. doi: 10.1055/s-2007-1002738. Semin Thromb Hemost. 1989. PMID: 2479104 Review. No abstract available.
-
Heparin induced bleeding.Nouv Rev Fr Hematol (1978). 1984;26(4):261-6. Nouv Rev Fr Hematol (1978). 1984. PMID: 6382162 Clinical Trial.
-
From unfractionated heparins to low molecular weight heparins.Acta Chir Scand Suppl. 1990;556:42-50. Acta Chir Scand Suppl. 1990. PMID: 1705072 Review.
-
Update in unfractionated heparin, low-molecular-weight heparins, and heparinoids in the elderly (age >/= 65 years).J Thromb Thrombolysis. 2000 Jan;9(1):117. doi: 10.1023/a:1018698231044. J Thromb Thrombolysis. 2000. PMID: 10590203 No abstract available.
-
Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.Thromb Haemost. 2007 Mar;97(3):496-7. Thromb Haemost. 2007. PMID: 17334521 No abstract available.
Cited by
-
Ancrod for coronary angioplasty.Tex Heart Inst J. 1995;22(4):342-6. Tex Heart Inst J. 1995. PMID: 8605439 Free PMC article.
-
The wonders of anticoagulation.Front Cardiovasc Med. 2025 Jan 13;11:1517109. doi: 10.3389/fcvm.2024.1517109. eCollection 2024. Front Cardiovasc Med. 2025. PMID: 39872878 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical